RxDoctor Payments Data

Gina Gustafson

Psychiatric/Mental Health · Mishawaka, INNPI 1700511193

Payments from drug & device makers

$3,323in general payments, 2019–2025

Across 158 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$415
  • AbbVie$414
  • Teva Pharmaceuticals USA, Inc.$400
  • Otsuka America Pharmaceutical, Inc.$379
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$243
  • E.r. Squibb & Sons, L.L.C.$188
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,21297%
  • Education$1113%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,323 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl15$29,826
CaplytaLumateperone Tosylate15$24,495
SpravatoEsketamine Hcl15$23,273
Loreev XrLorazepam13$7,024
Alprazolam ErAlprazolam12$1,048
Fluvoxamine Maleate17$559
Buspirone Hcl12$267
Alprazolam36$150
Quetiapine Fumarate11$97
Lamotrigine15$36

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$414$29,82615 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$243$24,49515 claims
Johnson & JohnsonSpravato$121$23,27315 claims
Almatica Pharma LLCLoreev Xr$99$7,02413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Mishawaka

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →